




* Department of Morphology and Embryology, Human Anatomy Section, University of Ferrara, Italy;
Department of Drug Sciences, "G. DAnnunzio" University of Chieti, Italy;
Department of Human Normal Morphology, University of Trieste, Italy; and
Hemostasis Research Center on Physiopathology of Hemostasis, Department of Histology, Catholic University of Rome, Italy
Correspondence: Giorgio Zauli, M.D., Ph.D., Department of Human Normal Morphology, University of Trieste, Via Manzoni 16, 34138 Trieste, Italy. E-mail: zauli{at}univ.trieste.it
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) up-regulated the expression of constitutive cyclooxygenase (COX)-1 protein in HL-60 cells without affecting COX-2. The TRAIL-mediated COX-1 up-regulation was accompanied by a significant increase of the PGE2 synthesis and release, which was suppressed by the COX-1 inhibitor valeryl salicylate but not by the COX-2 inhibitor NS-398. Experiments carried out by adding exogenous PGE2 to HL-60 cells indicated that PGE2 was not involved in TRAIL cytotoxicity and rather showed a dose-dependent protection against TRAIL-induced apoptosis. Importantly, the ability of TRAIL to increase PGE2 production was also observed in normal, human CD34-derived myeloid cells and in freshly isolated peripheral blood CD14+ monocytes. Moreover, in contrast to HL-60 cells, primary, normal cells were not susceptible to TRAIL cytotoxicity. These data indicate that the ability of TRAIL to up-regulate eicosanoid production and release is not confined to malignant leukemic cells, but it may also play a role in normal hematopoiesis.
Key Words: hematopoiesis signal transduction death receptor arachidonic acid
This article has been cited by other articles:
![]() |
H. Sun, E. Sheveleva, and Q. M. Chen Corticosteroids Induce Cyclooxygenase 1 Expression in Cardiomyocytes: Role of Glucocorticoid Receptor and Sp3 Transcription Factor Mol. Endocrinol., September 1, 2008; 22(9): 2076 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Teng, M. S. Brandwein-Gensler, M. S. Teixeira, J. A. Martignetti, and D. C. Duffey A Study of TRAIL Receptors in Squamous Cell Carcinoma of the Head and Neck Arch Otolaryngol Head Neck Surg, May 1, 2005; 131(5): 407 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Liberty, L. Raichel, Z. Hazan-Eitan, I. Pessach, N. Hadad, F. Schlaeffer, and R. Levy Cytosolic phospholipase A2 is responsible for prostaglandin E2 and leukotriene B4 formation in phagocyte-like PLB-985 cells: studies of differentiated cPLA2-deficient PLB-985 cells J. Leukoc. Biol., July 1, 2004; 76(1): 176 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Secchiero, D. Milani, A. Gonelli, E. Melloni, D. Campioni, D. Gibellini, S. Capitani, and G. Zauli Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-{alpha} promote the NF-{kappa}B-dependent maturation of normal and leukemic myeloid cells J. Leukoc. Biol., August 1, 2003; 74(2): 223 - 232. [Abstract] [Full Text] [PDF] |
||||